Chrysin mitigates bleomycin-induced pulmonary fibrosis in rats through regulating inflammation, oxidative stress, and hypoxia
- PMID: 33045575
- DOI: 10.1016/j.intimp.2020.107011
Chrysin mitigates bleomycin-induced pulmonary fibrosis in rats through regulating inflammation, oxidative stress, and hypoxia
Erratum in
-
Corrigendum to "Chrysin mitigates bleomycin-induced pulmonary fibrosis in rats through regulating inflammation, oxidative stress, and hypoxia" [Int. Immunopharm. 89(Part A) (2020) 107011].Int Immunopharmacol. 2023 Apr;117:109935. doi: 10.1016/j.intimp.2023.109935. Epub 2023 Mar 1. Int Immunopharmacol. 2023. PMID: 36868940 No abstract available.
Abstract
Pulmonary fibrosis is a chronic condition characterized by fibroblast proliferation, and the infiltration of inflammatory cells that can initiate local tissue hypoxia. In this study the effect of chrysin (50 mg/kg/orally) in a model of bleomycin (BLM)-induced pulmonary fibrosis was studied. Chrysin managed to decrease mortality rate associated with BLM instillation and it managed to improve lung architecture and lung fibrosis by decreasing hydroxyproline content and transforming growth factor-β1 (TGF-β1) protein expression. Chrysin showed anti-inflammatory effect displayed by the decrease in inflammatory cells infiltrates, the decline in permeability of the alveolar/capillary barrier and the reduction in lactate dehydrogenase (LDH) activity. Chrysin demonstrated potent antioxidant effect by decreasing lipid peroxidation, increasing antioxidant defense mechanisms by increasing superoxide dismutase (SOD) activity and reduced glutathione (GSH) content. Additionally, the effect of chrysin on nitric oxide (NOx) content was assessed, where chrysin decreased NOx, increased the protein expression of endothelial nitric oxide synthase (eNOS), and decreased inducible nitric oxide synthase (iNOS) protein expression. Chrysin also succeeded in decreasing thioredoxin-interacting protein (TXNIP), the negative regulator of thioredoxin system, showing potent antioxidant effect. Finally, both tissue and bronchoalveolar lavage fluid contents of hypoxia inducible factor one alpha (HIF1α) were decreased by chrysin indicating that chrysin decreased local tissue hypoxia. In conclusion, this study exposed a possible proof that chrysin could mitigate pulmonary fibrosis induced by BLM through its anti-inflammatory, antioxidant, antifibrotic effects and its effect in alleviating hypoxia.
Keywords: Bleomycin; Chrysin; HIF1α; Nitric oxide; TGF-β1; TXNIP.
Copyright © 2020 Elsevier B.V. All rights reserved.
Similar articles
-
Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-β1 and iNOS.Naunyn Schmiedebergs Arch Pharmacol. 2020 Sep;393(9):1659-1670. doi: 10.1007/s00210-020-01881-7. Epub 2020 May 6. Naunyn Schmiedebergs Arch Pharmacol. 2020. PMID: 32377772
-
Nicorandil ameliorates bleomycin-induced pulmonary fibrosis in rats through modulating eNOS, iNOS, TXNIP and HIF-1α levels.Life Sci. 2020 Apr 1;246:117423. doi: 10.1016/j.lfs.2020.117423. Epub 2020 Feb 11. Life Sci. 2020. PMID: 32057902
-
Protective effect of rutin against bleomycin induced lung fibrosis: Involvement of TGF-β1/α-SMA/Col I and III pathway.Biofactors. 2020 Jul;46(4):637-644. doi: 10.1002/biof.1629. Epub 2020 Mar 31. Biofactors. 2020. PMID: 32233122
-
The Cardiovascular Protective Effects of Chrysin: A Narrative Review on Experimental Researches.Cardiovasc Hematol Agents Med Chem. 2019;17(1):17-27. doi: 10.2174/1871525717666190114145137. Cardiovasc Hematol Agents Med Chem. 2019. PMID: 30648526 Free PMC article. Review.
-
Mechanisms of Bleomycin-induced Lung Fibrosis: A Review of Therapeutic Targets and Approaches.Cell Biochem Biophys. 2024 Sep;82(3):1845-1870. doi: 10.1007/s12013-024-01384-9. Epub 2024 Jul 2. Cell Biochem Biophys. 2024. PMID: 38955925 Review.
Cited by
-
Aerosol Delivery of Surfactant Liposomes for Management of Pulmonary Fibrosis: An Approach Supporting Pulmonary Mechanics.Pharmaceutics. 2021 Nov 3;13(11):1851. doi: 10.3390/pharmaceutics13111851. Pharmaceutics. 2021. PMID: 34834265 Free PMC article.
-
Anticancer potential of phytochemicals from Oroxylum indicum targeting Lactate Dehydrogenase A through bioinformatic approach.Toxicol Rep. 2022 Dec 14;10:56-75. doi: 10.1016/j.toxrep.2022.12.007. eCollection 2023. Toxicol Rep. 2022. PMID: 36583135 Free PMC article.
-
Multi‑omics analysis of right ventricles in rat models of pulmonary arterial hypertension: Consideration of mitochondrial biogenesis by chrysin.Int J Mol Med. 2022 May;49(5):69. doi: 10.3892/ijmm.2022.5124. Epub 2022 Mar 22. Int J Mol Med. 2022. PMID: 35315498 Free PMC article.
-
Betulin-rich hydroalcoholic extract of Daphne oleoides attenuates bleomycin-induced pulmonary fibrosis in rat.Heliyon. 2023 Aug 20;9(8):e19236. doi: 10.1016/j.heliyon.2023.e19236. eCollection 2023 Aug. Heliyon. 2023. PMID: 37664747 Free PMC article.
-
The Immunomodulatory Effects of Honey and Associated Flavonoids in Cancer.Nutrients. 2021 Apr 13;13(4):1269. doi: 10.3390/nu13041269. Nutrients. 2021. PMID: 33924384 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical